Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

  • Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Bone Therapeutics Reports Full Year 2017 Results

  • Read more about Bone Therapeutics Reports Full Year 2017 Results

Bone Therapeutics Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director

  • Read more about Bone Therapeutics Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Bone Therapeutics Business Update for First Quarter 2018

  • Read more about Bone Therapeutics Business Update for First Quarter 2018

The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available

  • Read more about The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Bone Therapeutics announces results of Annual General Meeting

  • Read more about Bone Therapeutics announces results of Annual General Meeting

The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available

  • Read more about The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions